Nature Neuroscience
2, 303 - 304 (1999)
doi:10.1038/7210
Anandamide: a candidate neurotransmitter heads for the big leaguesDavid W. Self
David Self is in the Division of Molecular Psychiatry, Yale University School of Medicine, Connecticut Mental Health Center, 34 Park St., New Haven, Connecticut 06508, USA. david.self@yale.edu
Activation of dopamine receptors triggers release of anandamide, an endogenous cannabinoid, in vivo, leading to inhibition of dopamine-mediated locomotor behavior.
|
